Clinical trial
Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2…
NCT00496548 · Vanderbilt University Medical Center, Other · Completed
Key facts
| NCT number | NCT00496548 |
|---|---|
| Title | Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity |
| Official title | Urinary PGE-M, A Metabolite of PGE2: A Novel Biomarker of Crohn's Disease Activity |
| Lead sponsor | Vanderbilt University Medical Center, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Procedure |
| Interventions | Fecal calprotectin, Urinary PGE-M Level |
| Enrollment | 159 |
| Start date | Aug 1, 2007 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Jul 4, 2007 |
| Last update posted | May 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: